Is tadalafil contraindicated in a patient with a prior surgically repaired retinal detachment?

Tadalafil is NOT contraindicated in patients with prior surgically repaired retinal detachment

There are no absolute contraindications to tadalafil use in patients with a history of repaired retinal detachment. The FDA label for tadalafil does not list prior retinal detachment as a contraindication 1. The only absolute contraindications are concurrent nitrate use, hypersensitivity reactions, and concomitant guanylate cyclase stimulators 1.

Key Evidence and Clinical Context

FDA-Approved Contraindications

The official tadalafil contraindications are limited to:

• Nitrate use (any form, regular or intermittent) 1
• Known serious hypersensitivity to tadalafil 1
• Concurrent guanylate cyclase stimulator use (e.g., riociguat) 1

Prior retinal detachment is notably absent from this list.

Retinal Detachment Risk Factors

The 2020 American Academy of Ophthalmology guidelines on retinal detachment extensively detail risk factors for rhegmatogenous retinal detachment (RRD), including myopia, lattice degeneration, cataract surgery, trauma, and prior detachment in the fellow eye 2. Phosphodiesterase-5 inhibitor use is not mentioned as a risk factor in these comprehensive guidelines.

Emerging Safety Signals - Important Caveats

While tadalafil is not contraindicated, recent pharmacovigilance data warrants caution:

• A 2025 FAERS database analysis identified erectile dysfunction medications (including tadalafil) among drugs with disproportionate retinal detachment reporting signals, with the longest median latency of 365 days 3
• However, this represents association, not causation, and the signal strength was lower than for ophthalmic agents and anticancer drugs 3

Case reports document exudative (serous) retinal detachment with tadalafil, not rhegmatogenous detachment:

• A 2022 case described bilateral neurosensory (exudative) retinal detachment that resolved after tadalafil discontinuation 4
• The proposed mechanism involves PDE5 inhibition causing choroidal vasodilation, increased hydrostatic pressure, and subretinal fluid exudation 4
• A 2012 case showed reversible photoreceptor damage mimicking serous detachment on OCT 5

Critical Distinction: Exudative vs. Rhegmatogenous Detachment

This distinction is crucial for your patient:

• Prior rhegmatogenous retinal detachment (with surgical repair) involves vitreoretinal traction and retinal breaks 2
• Tadalafil-associated detachments are exudative/serous in nature, involving choroidal vascular changes 4, 5
• These are fundamentally different pathophysiologic processes

Clinical Recommendation Algorithm

For patients with prior repaired rhegmatogenous retinal detachment:

1. Tadalafil may be prescribed - no absolute contraindication exists

2. Assess current retinal status:

   • Ensure successful repair with stable reattachment
   • Check for new risk factors: new myopia progression, recent cataract surgery, new lattice degeneration 2
   • Patients with prior RRD have 10% risk of fellow eye detachment regardless of medication use 2

3. Patient counseling is essential:

   • Warn about potential ocular side effects including transient visual changes
   • Educate on symptoms requiring immediate evaluation: new floaters, flashes, visual field defects, or vision loss
   • These symptoms warrant urgent ophthalmologic examination regardless of tadalafil use 2

4. Consider ophthalmology consultation if:

   • Multiple risk factors present (high myopia, lattice degeneration, recent cataract surgery)
   • Incomplete or recent retinal repair
   • Patient reports new visual symptoms

5. Monitor for choroidal/vascular changes:

   • Long-term tadalafil use can alter choroidal thickness and retinal vascular density 6, 7
   • These changes appear reversible but warrant awareness 6

Common Pitfalls to Avoid

• Do not confuse exudative detachment risk with rhegmatogenous detachment recurrence risk - these are separate entities
• Do not withhold tadalafil based solely on remote history of repaired RRD - this is not evidence-based
• Do not ignore new visual symptoms - any PDE5 inhibitor user with new floaters, flashes, or vision loss needs urgent retinal examination
• Do not assume all retinal detachments are the same - mechanism matters for risk assessment

The decision to prescribe tadalafil should weigh erectile dysfunction treatment benefits against theoretical ocular risks, with appropriate patient education and monitoring rather than blanket avoidance.